China, Sept. 25 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Prediction model construction and multi center validation of transarterial therapy for hepatocellular carcinoma'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600133304
Registration Time: 2026/09/24
Type: Observational study
Primary Sponsor: The First Affiliated Hospital of Guilin Medical University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=344978
Published by HT Digital Content Services with permission from Health Daily Digest....